Edition:
United Kingdom

CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

15.18HKD
22 Aug 2019
Change (% chg)

-- (--)
Prev Close
HK$15.18
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
33,869,749
52-wk High
HK$21.20
52-wk Low
HK$9.90

Latest Key Developments (Source: Significant Developments)

CSPC Pharmaceutical Group Says Anti-Tumor Drug Granted Clinical Trial Approval
Wednesday, 21 Aug 2019 

Aug 21 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::ANTI-TUMOR DRUG "SYHA1801" WAS GRANTED CLINICAL TRIAL APPROVAL BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION.UNIT GRANTED APPROVAL BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION TO CONDUCT CLINICAL TRIALS IN CHINA.  Full Article

Cspc Pharmaceutical Group Says Unit Enters Agreement With Synermore Biologics (Suzhou)
Monday, 19 Aug 2019 

Aug 19 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::UNIT ENTERED INTO AN AGREEMENT WITH SYNERMORE BIOLOGICS (SUZHOU) CO., LTD..UNDER DEAL, CSPC BAIKE TO PAY UPFRONT OF RMB10 MILLION, DEVELOPMENT MILESTONE PAYMENTS UP TO RMB50 MILLION TO SYNERMORE BIOLOGICS.AGREEMENT IN RELATION TO LICENSING AND COMMERCIALIZATION OF OMALIZUMAB BIOSIMILAR DEVELOPED BY SYNERMORE BIOLOGICS.UNIT HAS ALSO AGREED TO PAY SALES ROYALTY TO SYMERMORE BIOLOGICS BASED ON SALES AMOUNT OF PRODUCT ACHIEVED IN REGION.  Full Article

CSPC Pharmaceutical Group Posts HY Profit Attributable RMB1.88 Billion
Monday, 19 Aug 2019 

Aug 19 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::HY PROFIT ATTRIBUTABLE RMB1.88 BILLION VERSUS RMB1.50 BILLION LAST YEAR .HY TOTAL REVENUE RMB11.18 BILLION VERSUS RMB8.76 BILLION LAST YEAR.  Full Article

CSPC Pharmaceutical Group Says Zhang Cuilong Appointed As Vice-Chairman And Rotating CEO
Tuesday, 21 May 2019 

May 21 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::PAN WEIDONG CEASED AS VICE-CHAIRMAN OF COMPANY AND REMAINS AS EXECUTIVE DIRECTOR.WANG ZHENGUO CEASED AS VICE-CHAIRMAN AND ROTATING CHIEF EXECUTIVE OFFICER.ZHANG CUILONG APPOINTED AS VICE-CHAIRMAN AND ROTATING CHIEF EXECUTIVE OFFICER.WANG ZHENGUO REMAINS AS EXECUTIVE DIRECTOR.  Full Article

CSPC Pharmaceutical Says Unit And Shanghai Haihe Pharmaceutical Established A Joint Venture
Tuesday, 7 May 2019 

May 7 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::UNIT AND SHANGHAI HAIHE PHARMACEUTICAL ESTABLISHED A JOINT VENTURE FOR RESEARCH AND DEVELOPMENT OF INNOVATIVE DRUGS.REGISTERED CAPITAL OF JV RMB10 MILLION AND ITS EQUITY INTEREST IS OWNED AS TO 70% BY UNIT AND 30% BY HAIHE.  Full Article

CSPC Pharmaceutical Group Says "SYHA1803" Granted Clinical Trial Approval By NMPA China
Friday, 12 Apr 2019 

April 12 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::"SYHA1803" GRANTED APPROVAL BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA TO CONDUCT CLINICAL TRIALS IN CHINA.  Full Article

CSPC Pharmaceutical Group Says "SYHA1402" ‍Granted Clinical Trial Approval By NMPA China ​
Friday, 12 Apr 2019 

April 12 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::"SYHA1402" GRANTED APPROVAL BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA TO CONDUCT CLINICAL TRIALS IN CHINA.  Full Article

CSPC Pharmaceutical Group Unit To Acquire All Shares In Yong Shun
Monday, 7 Jan 2019 

Jan 7 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::DRAGON MERIT WILL ACQUIRE ALL ISSUED SHARES IN YONG SHUN FOR RMB252.9 MILLION.  Full Article

CSPC Pharmaceutical Group Says Unit To Buy 29.9 Pct Stake In CSPC Yuanda For RMB28 Mln
Monday, 6 Aug 2018 

Aug 6 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::UNIT TO BUY 29.9% EQUITY INTEREST IN CSPC YUANDA FROM CSPC HOLDINGS AT A CONSIDERATION OF RMB28 MILLION.  Full Article

CSPC Pharmaceutical Group Appoints Wang Zhenguo as Vice-Chairman And Rotating CEO
Friday, 25 May 2018 

May 25 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::PAN WEIDONG CEASED AS ROTATING CHIEF EXECUTIVE OFFICER.WANG ZHENGUO HAS BEEN APPOINTED AS VICE-CHAIRMAN AND ROTATING CHIEF EXECUTIVE OFFICER.PAN WEIDONG REMAINS AS EXECUTIVE DIRECTOR AND VICE- CHAIRMAN OF CO.  Full Article

Hong Kong stocks fall as protests, trade worries linger

Aug 22 Hong Kong stocks closed lower on Thursday, amid persistent worries over political protests and Sino-U.S. trade tensions.